Board of directors

Frank Lison

Chairman of the board
Frank Lison has 25 years of experience in the photonics industry. He received his PhD in Applied Physics from Bonn University, Germany. After starting his industrial career at Bayer AG, focusing on the development of tools for high throughput screening, Frank served as VP of Research & Development at TOPTICA Photonics. With two other investors he bought microscope manufacturer TILL Photonics from Agilent, turned it around and sold it to FEI Inc, then continued to work for FEI as Senior Director overseeing the business segment of cell biology.
Since leaving FEI, Frank is working as an independent consultant and serves his clients as board member, advisor, facilitator, or trainer in go to market strategies, technology, and product development.

 

Celia Hart

Board member
Celia Hart has more than 20 years’ experience in the chemical and biotechnology sectors. Before joining CEA Investissement in 2005, she was head of lead optimization at Cambridge Antibody Technology (UK) and marketing and commercial manager (ESRF, France).
She is currently investment director at CEA Investissement in charge of life sciences. Celia has a degree in chemistry (Geneva, CH), a PhD in chemistry (Oxford, UK) and an MBA (Grenoble EM, France).

 

François Thomas

Board member
Dr. François Thomas is general manager and managing partner of Inserm Transfert Initiative (ITI). He is a medical oncologist and a former assistant professor at the Gustave Roussy Institute. He also holds an MBA from MIT (Boston). François Thomas was successively vice president (VP) for clinical development of Ipsen, managing partner of Bioserve Ltd, VP in charge of pharmacogenomic programs and licensing at Genset, partner in the venture capital firm Atlas Venture, in charge of healthcare banking activities at Bryan Garnier, and president of Cytheris. His professional activity over the last 15 years has been dedicated to the creation and development of biotech companies in Europe.

 

Jérôme Feraud

Board Observer
Jérôme FERAUD degree holder in immunology, and of a diploma of the ITB, is Investment Manager of Viveris Management. He began his career in the finance within the Credit du Nord, after one year as a freelance web developer.He joigned the Audit and Valuation team of Viveris Management in 2006 before moving to the Capital Venture division in 2007.
Jerome FERAUD succeeded into performing investments in the Healthcare sector and was a Board member of most of these companies. He was notably administrator as well as censor during the initial public offerings of Ipsogen and Adocia.

 

Pierre Rivaux

Board Member
Pierre Rivaux has a long track record of success in the medtech industry. After graduating from Skema business school (Lille, France) he became a serial entrepreneur; his 2nd company was acquired by Tyco Healthcare (now Medtronic), which he joined first as Managing Director France, then Vice President EMEA. He then joined Intuitive Surgical (DaVinci robot) as Vice President International, bringing revenue to 230m$ in 5 years.
Subsequently he joined Leica Microsystems (Danaher) as Vice President EMEA, driving significant growth in 3 divisions (Life Science Research, Surgical Microscopy and Industry), with a direct staff of 400 plus 250 distributors, in 134 countries. Pierre is also member of the Board of Axilum Robotics.
Since leaving FEI, Frank is working as an independent consultant and serves his clients as board member, advisor, facilitator, or trainer in go to market strategies, technology, and product development.

 

Gabriel Sirat

Board Member

Gabriel Sirat is an inventor, a physicist and an engineer; he is a recognized world expert in crystal optics and instrumentation. He transforms theoretical concepts into practical systems, going from the blackboard to functional devices. During his Ph.D. at the Hebrew University of Jerusalem, he was the inventor of the first single pixel camera (1983). As a postdoc in Caltech, he invented Conoscopic Holography (1985), which evolved later on to become a major engineering technique, present in dental scanners or in metal inspection, as well as in many metrology fields. In 1989, he was appointed Professor at the prestigious Telecom Paris. He left Academia in 1992, in order to gain the freedom to invent and to be an entrepreneur. He co-founded Optimet, an optical metrology company and served there as CTO until 1996. He then went on to found several start-ups and was active in telecommunications, lithography, metrology and spectroscopy. Gabriel founded BioAxial in 2010 with a vision to conduct it towards excellence and leadership in super-resolution microscopy. He is the author of many scientific papers, and of more than 30 patents and patent applications, many of them being translated into practical devices and start-ups.